QFIN Q4 2025 Earnings Slight EPS Miss Amid Positive Stock Reaction Acrivon Therapeutics Q1 2026 Earnings Narrower Loss Per Share as Pipeline Progress Continues TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines PRIM Q1 2026 Earnings EPS Misses Estimates by 315 Amid Operational Headwinds Leggett Platt Q1 2026 Earnings EPS Misses Estimates as Profitability Pressures Persist ORLY Q1 2026 Earnings EPS Beats Estimates amid Solid Execution